Importer of Controlled Substances; Notice of Application: Johnson Matthey, Inc., 69130 [2013-27448]
Download as PDF
69130
Federal Register / Vol. 78, No. 222 / Monday, November 18, 2013 / Notices
other public and private entities that
apply for COPS Office grants or
cooperative agreements will be asked
complete the COPS Application
Package. The COPS Application Package
includes all of the necessary forms and
instructions that an applicant needs to
review and complete to apply for COPS
grant funding. The package is used as a
standard template for all COPS
programs.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that 5000
respondents annually will complete the
form within 11 hours.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated
55,000 total annual burden hours
associated with this collection.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Washington
DC 20530.
Dated: November 12, 2013.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2013–27467 Filed 11–15–13; 8:45 am]
BILLING CODE 4410–AT–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application: Johnson
Matthey, Inc.
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on September 5, 2013, Johnson
Matthey, Inc., Pharmaceutical Materials,
2003 Nolte Drive, West Deptford, New
Jersey 08066–1742, made application by
renewal to the Drug Enforcement
Administration (DEA) for registration as
an importer of the following basic
classes of controlled substances:
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
In reference to the non-narcotic raw
material, the company plans to import
gram amounts to be used as reference
standards for sale to its customers. Any
bulk manufacturer who is presently, or
is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances listed in
schedules I or II, which fall under the
authority of section 1002(a)(2)(B) of the
Act (21 U.S.C. 952(a)(2)(B)) may, in the
circumstances set forth in 21 U.S.C.
958(i), file comments or objections to
the issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODW), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than December 18, 2013.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745, all applicants for
registration to import a basic class of
any controlled substance in schedules I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. § 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: November 4, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–27448 Filed 11–15–13; 8:45 am]
BILLING CODE 4410–09–P
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug
Schedule
Coca Leaves (9040) .....................
Thebaine (9333) ...........................
Opium, raw (9600) .......................
Noroxymorphone (9668) ..............
Poppy Straw Concentrate (9670)
II
II
II
II
II
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
The company plans to import the
listed controlled substances as raw
materials, to be used in the manufacture
of bulk controlled substances, for
distribution to its customers.
VerDate Mar<15>2010
17:33 Nov 15, 2013
Jkt 232001
Importer of Controlled Substances;
Notice of Application; Cerilliant
Corporation
Pursuant to Title 21 Code of Federal
Regulations 1301.34(a), this is notice
that on July 16, 2013, Cerilliant
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402, made
application to the Drug Enforcement
Administration (DEA) for registration as
an importer of the following basic
classes of controlled substances:
Drug
Methaqualone (2565) ...................
JWH–250 (6250) ..........................
SR–18 also known as RCS–8
(7008).
XLR11 (7011) ...............................
JWH–019 (7019) ..........................
AKB48 (7048) ...............................
JWH–081 (7081) ..........................
SR–19 also known as RCS–4
(7104).
JWH–122 (7122) ..........................
UR–144 (7144) .............................
AM–2201 (7201) ...........................
JWH–203 (7203) ..........................
Parahexyl (7374) ..........................
2C–T–2 (7385) .............................
JWH–398 (7398) ..........................
5-Methoxy-3,4-methylenedioxyamphetamine (7401).
N-Hydroxy-3,4-methylenedioxyamphetamine (7402).
Bufotenine (7433) .........................
N-Ethyl-1-phenylcyclohexylamine
(7455).
1-(1-Phenylcyclohexyl)pyrrolidine
(7458).
1-(1-Phenylcyclohexyl)pyrrolidine
(7470).
2C–D (7508) .................................
2C–E (7509) .................................
2C–H (7517) .................................
2C–I (7518) ..................................
2C–C (7519) .................................
2C–N (7521) .................................
2C–P (7524) .................................
2C–T–4 (7532) .............................
AM–694 (7694) .............................
Codeine methylbromide (9070) ....
Acetylmethadol (9601) .................
Allylprodine (9602) .......................
Alphacetylmethadol except levoalphacetylmethadol (9603).
Alphameprodine (9604) ................
Alphamethadol (9605) ..................
Benzethidine (9606) .....................
Betacetylmethadol (9607) ............
Betameprodine (9608) ..................
Betamethadol (9609) ....................
Betaprodine (9611) .......................
Hydroxypethidine (9627) ..............
Noracymethadol (9633) ................
Norlevorphanol (9634) ..................
Normethadone (9635) ..................
Para-Fluorofentanyl (9812) ..........
3-Methylfentanyl (9813) ................
Alpha-methylfentanyl (9814) ........
Acetyl-alpha-methylfentanyl
(9815).
Beta-hydroxyfentanyl (9830) ........
Beta-hydroxy-3-methylfentanyl
(9831).
Alpha-methylthiofentanyl (9832) ...
3-Methylthiofentanyl (9833) ..........
Thiofentanyl (9835) ......................
Lisdexamfetamine (1205) .............
Glutethimide (2550) ......................
Nabilone (7379) ............................
E:\FR\FM\18NON1.SGM
18NON1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
Agencies
[Federal Register Volume 78, Number 222 (Monday, November 18, 2013)]
[Notices]
[Page 69130]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27448]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application: Johnson
Matthey, Inc.
Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on September 5, 2013, Johnson Matthey, Inc.,
Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey
08066-1742, made application by renewal to the Drug Enforcement
Administration (DEA) for registration as an importer of the following
basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Coca Leaves (9040)......................... II
Thebaine (9333)............................ II
Opium, raw (9600).......................... II
Noroxymorphone (9668)...................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances as raw
materials, to be used in the manufacture of bulk controlled substances,
for distribution to its customers.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417 (2007).
In reference to the non-narcotic raw material, the company plans to
import gram amounts to be used as reference standards for sale to its
customers. Any bulk manufacturer who is presently, or is applying to
be, registered with DEA to manufacture such basic classes of controlled
substances listed in schedules I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in
the circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODW), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than December 18, 2013.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, 40 FR 43745, all applicants for
registration to import a basic class of any controlled substance in
schedules I or II are, and will continue to be, required to demonstrate
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, that the requirements for such
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. Sec. 823(a); and
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: November 4, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-27448 Filed 11-15-13; 8:45 am]
BILLING CODE 4410-09-P